VANDA PHARMACEUTICALS INC. (VNDA) Return on equity 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.4%FY2025 · since FY2016: -13.7% → -67.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.4% | -63.9 pp |
| FY2024 | -3.5% | -4.0 pp |
| FY2023 | 0.5% | -0.7 pp |
| FY2022 | 1.2% | -5.4 pp |
| FY2021 | 6.6% | +1.4 pp |
| FY2020 | 5.1% | -23.0 pp |
| FY2019 | 28.1% | +19.0 pp |
| FY2018 | 9.2% | +21.0 pp |
| FY2017 | -11.8% | +1.9 pp |
| FY2016 | -13.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VNDA financial trends
VNDA RevenueVNDA Net incomeVNDA Net marginVNDA Gross profitVNDA Gross marginVNDA Operating incomeVNDA Operating marginVNDA Operating cash flowVNDA Free cash flowVNDA Capital expendituresVNDA Stock buybacksVNDA Dividends paidVNDA Total assetsVNDA Total liabilitiesVNDA Shareholders’ equityVNDA overview →